Manufacture of pharmaceutical preparations
ALGINOR PHARMA INGREDIENTS AS
Operating profit
NOK −317,000
Equity
NOK 9.8m
Incorporated
2021
Share capital
NOK 10.0m
Key figures · 2024
Current ratio
0.27
Equity ratio
29.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -1.0% | |
| Likviditet | ||
| Current ratio | 0.27 | |
| Working capital | −17.0m | |
| Soliditet | ||
| Equity ratio (%%) | 29.6% | |
| Debt-to-equity ratio | 2.38 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.